Literature DB >> 29237332

Traditional, complementary, and alternative medical cures for HIV: rationale and implications for HIV cure research.

Xin Pan1, Alice Zhang1,2, Gail E Henderson3, Stuart Rennie3, Chuncheng Liu1, Weiping Cai4, Feng Wu1, Joseph D Tucker1,5.   

Abstract

Traditional, complementary, and alternative medicine (TCAM) has been used by some people living with HIV (PLHIV) in an attempt to cure HIV. This article reviews the main factors influencing their decision to choose TCAM to cure HIV and discusses implications for HIV cure research. Those who decide to pursue traditional, complementary, and alternative medical cures may be influenced by the health system, cultural, and social dynamics, and their own individual beliefs and preferences. These same factors may impact participation in HIV cure research. People who search for traditional, complementary, and alternative medical cures may face special challenges as they are recruited, consented, and retained within HIV cure research studies. To address these potential challenges, we have suggested solutions focusing on culturally tailored communication and education, formative social science research, and community partnerships with key stakeholders. The social conditions that have promoted traditional, complementary and alternative medical cures will likely impact how PLHIV participate and experience HIV remission trials. Despite the potential challenges, it will be crucial to involve those who have previously sought out traditional cures for HIV in HIV cure research.

Entities:  

Keywords:  HIV cure research; HIV/AIDS; complementary and alternative medicine; cure; traditional medicine

Mesh:

Year:  2017        PMID: 29237332      PMCID: PMC6092229          DOI: 10.1080/17441692.2017.1413122

Source DB:  PubMed          Journal:  Glob Public Health        ISSN: 1744-1692


  53 in total

1.  Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism.

Authors:  Sam Horng; Christine Grady
Journal:  IRB       Date:  2003 Jan-Feb

2.  Biomedical loopholes, distrusted state, and the politics of HIV/AIDS "cure" in Nigeria.

Authors:  Ebenezer Obadare; Iruka N Okeke
Journal:  Afr Aff (Lond)       Date:  2011

3.  Integration for coexistence? Implementation of intercultural health care policy in Ghana from the perspective of service users and providers.

Authors:  Razak Mohammed Gyasi; Adjoa Afriyie Poku; Simon Boateng; Padmore Adusei Amoah; Alhassan Abdul Mumin; Jacob Obodai; Williams Agyemang-Duah
Journal:  J Integr Med       Date:  2017-01

4.  Words matter: Discussing research towards an HIV cure in research and clinical contexts.

Authors:  Joseph D Tucker; Paul A Volberding; David M Margolis; Stuart Rennie; Françoise Barré-Sinoussi
Journal:  J Acquir Immune Defic Syndr       Date:  2014-11-01       Impact factor: 3.731

5.  Natural health product-HIV drug interactions: a systematic review.

Authors:  Edward Mills; Victor Montori; Dan Perri; Elizabeth Phillips; Gideon Koren
Journal:  Int J STD AIDS       Date:  2005-03       Impact factor: 1.359

6.  Setting the context for research: exploring the philosophy and environment of a cancer clinical trials unit.

Authors:  K Cox
Journal:  J Adv Nurs       Date:  2000-11       Impact factor: 3.187

7.  The meaning of complementary and alternative medicine practices among people with HIV in the United States: strategies for managing everyday life.

Authors:  Carrie E Foote-Ardah
Journal:  Sociol Health Illn       Date:  2003-07

8.  Novel strategies implemented to ensure high participant retention rates in a community based HIV prevention effectiveness trial in South Africa and Zimbabwe.

Authors:  Sharika Gappoo; Elizabeth T Montgomery; Caitlin Gerdts; Sarita Naidoo; Agnes Chidanyika; Busi Nkala; Gita Ramjee
Journal:  Contemp Clin Trials       Date:  2009-05-28       Impact factor: 2.226

9.  Improving understanding of clinical trial procedures among low literacy populations: an intervention within a microbicide trial in Malawi.

Authors:  Paul M Ndebele; Douglas Wassenaar; Esther Munalula; Francis Masiye
Journal:  BMC Med Ethics       Date:  2012-11-08       Impact factor: 2.652

10.  Knowledge, Attitudes, and Experiences of HIV Pre-Exposure Prophylaxis (PrEP) Trial Participants in Botswana.

Authors:  Lauren Toledo; Eleanor McLellan-Lemal; Faith L Henderson; Poloko M Kebaabetswe
Journal:  World J AIDS       Date:  2015-02-12
View more
  4 in total

1.  Medicinal plant use, conservation, and the associated traditional knowledge in rural communities in Eastern Uganda.

Authors:  Jamilu E Ssenku; Shaban A Okurut; Aidah Namuli; Ali Kudamba; Patience Tugume; Paul Matovu; Godfrey Wasige; Hussein M Kafeero; Abdul Walusansa
Journal:  Trop Med Health       Date:  2022-06-06

2.  Re-examining the HIV 'functional cure' oxymoron: Time for precise terminology?

Authors:  Karine Dubé; Loreen Willenberg; Lynda Dee; Laurie Sylla; Jeff Taylor; Christopher Roebuck; David Palm; Danielle Campbell; Luke Newton; Hursch Patel; Kelly E Perry; John Kanazawa; Jo Gerrard; Brandon Brown; Parya Saberi; John A Sauceda; Michael J Peluso
Journal:  J Virus Erad       Date:  2020-10-14

Review 3.  Ethics of HIV cure research: an unfinished agenda.

Authors:  Karine Dubé; John Kanazawa; Jeff Taylor; Lynda Dee; Nora Jones; Christopher Roebuck; Laurie Sylla; Michael Louella; Jan Kosmyna; David Kelly; Orbit Clanton; David Palm; Danielle M Campbell; Morénike Giwa Onaiwu; Hursch Patel; Samuel Ndukwe; Laney Henley; Mallory O Johnson; Parya Saberi; Brandon Brown; John A Sauceda; Jeremy Sugarman
Journal:  BMC Med Ethics       Date:  2021-06-30       Impact factor: 2.834

4.  Antibiotic-resistance in medically important bacteria isolated from commercial herbal medicines in Africa from 2000 to 2021: a systematic review and meta-analysis.

Authors:  Abdul Walusansa; Savina Asiimwe; Jesca L Nakavuma; Jamilu E Ssenku; Esther Katuura; Hussein M Kafeero; Dickson Aruhomukama; Alice Nabatanzi; Godwin Anywar; Arthur K Tugume; Esezah K Kakudidi
Journal:  Antimicrob Resist Infect Control       Date:  2022-01-21       Impact factor: 4.887

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.